During the past decade, Washington University School of Medicine Center for Advanced Medicine conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 5 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Washington University School of Medicine Center for Advanced Medicine" #1 sponsor was "Pfizer" with 3 trials, followed by "Amgen" with 1 trials sponsored, "Bristol-Myers Squibb" with 1 trials sponsored, "Calliditas Therapeutics Suisse SA" with 1 trials sponsored and "Cardiff Oncology" with 1 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Washington University School of Medicine Center for Advanced Medicine" #1 collaborator was "Merck Sharp & Dohme LLC" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Washington University School of Medicine Center for Advanced Medicine" are "Advanced Cancer" (2 trials), "Breast Cancer" (1 trials), "Colorectal Cancer" (1 trials), "Cutaneous or Subcutaneous Lymph Node" (1 trials) and "Diabetes Mellitus, Type 1" (1 trials). Many other conditions were trialed in "Washington University School of Medicine Center for Advanced Medicine" in a lesser frequency.

Most popular intervention types in "Washington University School of Medicine Center for Advanced Medicine" are "Drug" (11 trials), "Biological" (3 trials), "Other" (3 trials) and "Radiation" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Pembrolizumab" (2 trials), "ARRY-371797 (PF-07265803)" (1 trials), "Anastrozole Tablets" (1 trials) and "BMS-986205" (1 trials). Other intervention names were less common.

The vast majority of trials in "Washington University School of Medicine Center for Advanced Medicine" are 11 trials for "All" genders.

Currently, there are NaN active trials in "Washington University School of Medicine Center for Advanced Medicine". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Washington University School of Medicine Center for Advanced Medicine, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Washington University School of Medicine Center for Advanced Medicine, 3 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".